1345686-06-7

Upstream product

• 957063-06-8 (5-bromopyridin-2-yl)-(morpholin-4-yl)methanone 
• 1345688-10-9 1-{4-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]phenyl}-5-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole 
• 215656-99-8 4-{[tert-butyl(dimethyl)silyl]oxy}-2-nitroaniline 
• 1345687-97-9 1-{4-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]phenyl}-1H-benzimidazol-5-yl trifluoromethanesulfonate 
• 1345687-95-7 1-{4-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]phenyl}-1H-benzimidazol-5-ol 
• 1345687-93-5 5-{ [tert-butyl(dimethyl)silyl]oxy}-1-{4-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]phenyl}-1H-benzimidazole 
• 1345687-91-3 4-{ [tert-butyl(dimethyl)silyl]oxy}-N¹-{4-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]phenyl}benzene-1,2-diamine 
• 1345687-89-9 4-{[tert-butyl(dimethyl)silyl]oxy}-2-nitro-N-{4-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]phenyl}aniline 
• 610-81-1 4-hydroxy-2-nitroaniline 

Relevant academic research and scientific papers

[5,6]HETEROCYCLIC COMPOUND

Abstract: An object of the present invention is to provide a novel low molecular weight compound exhibiting an osteogenesis-promoting action. This object is achieved by a compound having the general formula (I) or a pharmacologically acceptable salt thereof. In the general formula (I), R1 and R2 represent hydrogen atoms, and the like; R3 represents a hydrogen atom, and the like; X, Y, and Z represent nitrogen atoms, and the like; A represents a phenylene group, and the like; n represents 1 or 2, and the like; and V and W represent oxygen atoms, and the like.